244 results
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
,” “projects,” “positioned,” “strategy” and similar expressions and are based on assumptions and assessments made in light of management’s experience
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
,” “will,” “expects,” “estimates,” “projects,” “positioned,” “strategy” and similar expressions and are based on assumptions and assessments made in light
8-K
EX-99.1
675jymg
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
EX-99.1
x2ec2u4xdwh 0fw
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
2j2k48z be4dlwng
7 Apr 23
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
4:41pm
NT 10-K
m9f4lip4y70psy55 yw
31 Mar 23
Notice of late annual filing
5:02pm
8-K
74j0lbj
1 Dec 22
Entry into a Material Definitive Agreement
9:23am
8-K
EX-99.1
zbmpmsau3tgb wxsfdra
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm
8-K
EX-99.1
uulms1ku 9725a6u
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-99.1
68nj8
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
lm0q0j
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am